Apollo Hospitals

75
Buy
  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: INE437A01024
  • NSEID: APOLLOHOSP
  • BSEID: 508869
INR
8,980.50
167.6 (1.9%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 2.84 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
25,228.00
21,794.00
19,059.00
16,612.00
14,662.00
10,560.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
25,228.00
21,794.00
19,059.00
16,612.00
14,662.00
10,560.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
-1.00
-33.00
-24.00
-73.00
-125.00
Raw Materials Consumed
13,097.00
11,311.00
9,839.00
8,598.00
7,646.00
5,809.00
Power & Fuel Cost
281.00
266.00
247.00
217.00
193.00
169.00
Employee Cost
3,000.00
2,769.00
2,493.00
2,176.00
1,786.00
1,601.00
Operating Expenses
3,122.00
2,555.00
2,089.00
1,786.00
1,582.00
878.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
443.00
531.00
658.00
639.00
364.00
199.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
218.00
171.00
141.00
141.00
137.00
136.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
21,459.00
18,772.00
16,668.00
14,562.00
12,477.00
9,422.00
Operating Profit (PBDIT) excl Other Income
3,769.00
3,021.00
2,390.00
2,049.00
2,185.00
1,137.00
Other Income
191.00
200.00
106.00
90.00
78.00
45.00
Operating Profit (PBDIT)
3,960.00
3,222.00
2,497.00
2,139.00
2,263.00
1,182.00
Interest
449.00
458.00
449.00
380.00
378.00
449.00
Profit before Depriciation and Tax
3,511.00
2,763.00
2,047.00
1,759.00
1,884.00
733.00
Depreciation
876.00
757.00
687.00
615.00
600.00
573.00
Profit Before Taxation & Exceptional Items
2,635.00
2,006.00
1,360.00
1,143.00
1,284.00
160.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,660.00
2,039.00
1,380.00
1,143.00
1,578.00
220.00
Provision for Tax
658.00
534.00
445.00
256.00
477.00
84.00
Profit After Tax
1,957.00
1,472.00
917.00
887.00
1,101.00
136.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,941.00
2,772.00
2,059.00
1,600.00
593.00
426.00
Profit Available for appropriations
5,882.00
4,218.00
2,957.00
2,419.00
1,648.00
576.00
Appropriations
5,882.00
4,218.00
2,957.00
2,419.00
1,648.00
576.00
Equity Dividend (%)
400.00%
253.20%
320.00%
300.00%
235.00%
60.00%
Earnings Per Share
135.04
100.56
62.50
56.97
73.42
10.74
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 15.76% vs 14.35% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 24.74% vs 26.40% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -1.94% vs 2.02% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 32.99% vs 60.53% in Mar 2025

Compare Profit and Loss Results of Apollo Hospitals
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
25,228.00
8,373.00
16,855.00
201.30%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
25,228.00
8,373.00
16,855.00
201.30%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
-8.00
-13.00
-162.50%
Raw Materials Consumed
13,097.00
1,798.00
11,299.00
628.42%
Power & Fuel Cost
281.00
121.00
160.00
132.23%
Employee Cost
3,000.00
1,357.00
1,643.00
121.08%
Operating Expenses
3,122.00
2,052.00
1,070.00
52.14%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
443.00
119.00
324.00
272.27%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
218.00
128.00
90.00
70.31%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
21,459.00
6,130.00
15,329.00
250.07%
Operating Profit (PBDIT) excl Other Income
3,769.00
2,242.00
1,527.00
68.11%
Other Income
191.00
162.00
29.00
17.90%
Operating Profit (PBDIT)
3,960.00
2,405.00
1,555.00
64.66%
Interest
449.00
235.00
214.00
91.06%
Profit before Depriciation and Tax
3,511.00
2,170.00
1,341.00
61.80%
Depreciation
876.00
446.00
430.00
96.41%
Profit Before Taxation & Exceptional Items
2,635.00
1,723.00
912.00
52.93%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,660.00
1,675.00
985.00
58.81%
Provision for Tax
658.00
233.00
425.00
182.40%
Profit After Tax
1,957.00
1,442.00
515.00
35.71%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,941.00
3,110.00
831.00
26.72%
Profit Available for appropriations
5,882.00
4,553.00
1,329.00
29.19%
Appropriations
5,882.00
4,553.00
1,329.00
29.19%
Equity Dividend (%)
400%
20%
380.00
Earnings Per Share
135.04
14.83
120.21
810.59%
Profit And Loss - Net Sales
Net Sales 25,228.50 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.76% vs 14.35% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,769.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 24.74% vs 26.40% in Mar 2025

Profit And Loss - Interest
Interest 449.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.94% vs 2.02% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1,957.80 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 32.99% vs 60.53% in Mar 2025